Avon Whitening Essentials

Description

PERIOE Whitening Essentials is a fluoride toothpaste formulated for cavity protection and teeth whitening. This product is designed to help remove surface stains, utilizing a 10X charcoal component to enhance its whitening efficacy. The toothpaste is presented in a black formulation with a clean mint flavor. Each tube contains a net weight of 5.5 oz (156 g).

Uses and Indications

This drug is indicated for the protection against cavities.

There are no teratogenic effects associated with this drug. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

Adults and children aged 6 years and older are advised to brush their teeth thoroughly after each meal or at least twice daily, or as directed by a dentist or physician. It is important to ensure that the product is not swallowed.

For children between the ages of 6 and 12 years, a pea-sized amount of the product should be used to minimize the risk of swallowing. Caregivers should supervise the brushing and rinsing process until proper oral hygiene habits are established.

For children under 6 years of age, it is recommended to consult a dentist or physician for appropriate guidance on usage.

Contraindications

The product should not be swallowed. In the event that more than the recommended amount for brushing is accidentally ingested, seek medical assistance or contact a Poison Control Center immediately. Additionally, if an allergic reaction occurs, discontinue use without delay.

Warnings and Precautions

It is imperative to keep this product out of the reach of children under 6 years of age. The product is not intended for swallowing. In the event that more than the recommended amount for brushing is accidentally ingested, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Healthcare professionals should advise patients to discontinue use immediately if any signs of an allergic reaction occur. Prompt communication with a healthcare provider is essential in such cases to ensure appropriate management and care.

No specific general precautions or laboratory tests are indicated for the safe use of this product. However, vigilance in monitoring for adverse reactions is recommended to ensure patient safety.

Side Effects

Patients may experience adverse reactions during treatment. In the event of an allergic reaction, it is imperative to discontinue use immediately.

Clinical trials and postmarketing experiences have provided insights into the safety profile of the treatment. It is essential for healthcare providers to monitor patients for any signs of adverse reactions and to take appropriate action if necessary.

Drug Interactions

There are no specific drug interactions identified for this medication. Additionally, no laboratory test interactions have been reported. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Avon Whitening Essentials (sodium fluoride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be kept out of reach of children under 6 years of age. For children between 6 and 12 years, it is recommended to use a pea-sized amount to minimize swallowing, and caregivers should supervise brushing and rinsing until proper oral hygiene habits are established. For children under 6 years, consultation with a dentist or physician is advised. In the event that more than the recommended amount is accidentally swallowed, medical assistance or contact with a Poison Control Center should be sought immediately.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients should be aware that the safety of this medication during pregnancy has not been established. There are no available data regarding the potential risks or fetal outcomes associated with the use of this medication in pregnant individuals. Healthcare professionals are advised to consider the lack of information when prescribing this medication to women of childbearing potential and to discuss the potential risks and benefits with their patients. It is recommended that pregnant patients or those planning to become pregnant consult their healthcare provider for personalized advice and to explore alternative treatment options if necessary.

Lactation

There are no specific warnings or recommendations regarding nursing mothers. Additionally, there are no specific considerations or precautions mentioned related to lactation.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise clinical judgment when considering the use of this medication in patients with liver problems, as the absence of specific guidance necessitates careful evaluation of the patient's overall health status and liver function.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If an individual accidentally swallows more than the amount typically used for brushing, it is imperative to seek medical help or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt intervention can mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved, and monitoring the patient closely is essential.

Management procedures should include assessing the patient's condition and providing supportive care as necessary. It is advisable to have the product's labeling and any relevant medical history available when contacting medical professionals or poison control for guidance.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to elucidate these aspects of nonclinical toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children under 6 years of age to prevent accidental ingestion.

Patients should be informed not to swallow the product. In the event that more than the recommended amount used for brushing is accidentally swallowed, they should seek medical help or contact a Poison Control Center immediately.

Additionally, healthcare providers should instruct patients to discontinue use immediately if any signs of an allergic reaction develop. It is important for patients to be aware of these potential risks and to act promptly should they occur.

Storage and Handling

The product is supplied in configurations that include specific NDC numbers. It should be stored at room temperature, ensuring that it is protected from freezing conditions. Once opened, the product must be discarded to maintain safety and efficacy.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Avon Whitening Essentials, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)